Results 281 to 290 of about 24,558,950 (403)

Phase Change of an Exploding Wire in Water

, 1976
Mikio Motoki, Ken Yukimura
openalex   +2 more sources

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Rapid learning with phase-change memory-based in-memory computing through learning-to-learn. [PDF]

Nat Commun
Ortner T, Petschenig H, Vasilopoulos A, Renner R, Brglez Š, Limbacher T, Piñero E, Linares-Barranco A, Pantazi A, Legenstein R.   +9 more
europepmc   +1 more source

Quasi-steady droplet phase change in the presence of convection

, 1979
John K. Dukowicz
openalex   +1 more source

Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?

Molecular Oncology, EarlyView.
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley   +1 more source

A Novel Concept of Nano-Enhanced Phase Change Material. [PDF]

Materials (Basel)
Calotă R, Pop O, Bode F, Croitoru C, Serafim A, Bărbulescu A, Damian C, Tefas L.   +7 more
europepmc   +1 more source

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

Molecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen, Chung‐Teng Wang, Jia‐Ming Chang, Ai‐Li Shiau, Gia‐Shing Shieh, Yau‐Lin Tseng, Yi‐Ting Yen, Tang‐Hsiu Huang, Li‐Hsin Cheng, Yu‐Chih Wu, Chao‐Liang Wu, Bing‐Hua Su, Pensee Wu   +12 more
wiley   +1 more source

Electrical Control of Magnetic Resonance in Phase Change Materials. [PDF]

Nano Lett
Chen TY, Ren H, Ghazikhanian N, Hage RE, Sasaki DY, Salev P, Takamura Y, Schuller IK, Kent AD.   +8 more
europepmc   +1 more source

Kinetics on Uptake of Drugs in Goldfish. I. Effect of pH Change in Water Phase and Addition of Polyethylene Glycol 6000 and Urea on Uptake of Salicylic Acid

, 1974
Yoko Sakiya, NOBUAKI UMEZAWA, Manabu Hanano   +2 more
openalex   +2 more sources

Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence

Molecular Oncology, EarlyView.
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova, Dominika Maurencova, Barbora Salovska, Marek Kratky, Tomas Mracek, Zuzana Korandova, Alena Pecinova, Pavla Vasicova, David Rysanek, Ladislav Andera, Ivo Fabrik, Rudolf Kupcik, Pavel Kashmel, Pinky Sultana, Vojtech Tambor, Jiri Bartek, Josef Novak, Marie Vajrychova, Zdenek Hodny   +18 more
wiley   +1 more source